NCT03764098View on ClinicalTrials.gov

Mechanistic Evaluation of Guanfacine on Drinking Behavior in Women and Men With Alcohol Use Disorders

PHASE2RecruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

August 10, 2020

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Alcohol Use
Interventions
DRUG

Guanfacine ER

Guanfacine Extended Release (6mg/day ER)

OTHER

Placebo

Placebo

Trial Locations (1)

06510

RECRUITING

Yale University School of Medicine, New Haven

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Yale University

OTHER